|
Market Closed -
NYSE
16:00:02 2026-11-06 EST
|
5-day change | 1st Jan Change | ||
| 101.80 USD | -2.90% |
|
+5.45% | +5.98% |
| Market Cap | 125B 112B 102B 93.24B 176B 11,714B 181B 1,231B 491B 6,251B 468B 458B 19,732B | P/E 2027 * |
22x | P/E 2028 * | 20.1x |
|---|---|---|---|---|---|
| Enterprise Value | 146B 131B 119B 109B 205B 13,697B 212B 1,440B 574B 7,308B 547B 535B 23,072B | EV / Sales 2027 * |
3.74x | EV / Sales 2028 * | 3.56x |
| Free-Float |
99.65% | Yield 2027 * |
2.79% | Yield 2028 * | 2.97% |
| Markets | Quality | ||
|---|---|---|---|
NYSE
| MDT | Delayed | |
CBOE
| MDT | Real-time | |
Tradegate
| 2M6 | Real-time | |
Xetra
| 2M6 | Delayed | |
London S.E.
| 0Y6X | Delayed | |
Deutsche Boerse AG
| 2M6 | Delayed | |
Boerse Muenchen
| 2M6 | Real-time | |
Börse Stuttgart
| 2M6 | Delayed | |
Mexican S.E.
| MDT N | End-of-day quote | |
Wiener Boerse
| MDT | End-of-day quote | |
Borsa Italiana
| 1MDT | End-of-day quote | |
Swiss Exchange
| MDT | Delayed | |
Bulgaria S.E.
| 2M6 | End-of-day quote | |
Swiss Exchange
| MDT | Delayed |
Last Transcript: Medtronic plc
| 1 day | -2.90% | ||
| 1 week | +5.45% | ||
| Current month | +5.45% | ||
| 1 month | +19.05% | ||
| 3 months | +16.80% | ||
| 6 months | +30.58% | ||
| Current year | +5.98% |
| 1 week | 96.75 | 106.2 | |
| 1 month | 87.4 | 106.2 | |
| Current year | 73.31 | 106.2 | |
| 1 year | 73.31 | 106.33 | |
| 3 years | 69.32 | 106.33 | |
| 5 years | 68.84 | 123.87 | |
| 10 years | 68.84 | 135.89 |
| Manager | Title | Age | Since |
|---|---|---|---|
Geoffrey Martha
CEO | Chief Executive Officer | 56 | 2020-04-26 |
Michael Marinaro
PSD | President | - | 2026-10-13 |
Thierry Pieton
DFI | Director of Finance/CFO | 56 | 2025-03-02 |
| Director | Title | Age | Since |
|---|---|---|---|
Craig Arnold
BRD | Director/Board Member | 66 | 2015-01-25 |
Scott Donnelly
BRD | Director/Board Member | 64 | 2012-12-31 |
Randall Hogan
BRD | Director/Board Member | 70 | 2014-12-31 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 10/15/26 | Sell | EVP, Pres MedSurg and Americas | -10,420 | 0.0008% | ||
| 10/15/26 | Sell | Chief Executive Officer | -50,000 | 0.0039% | ||
| 9/16/26 | Sell | Executive/Senior Manager | -1,483 | 0.0001% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
| -2.90% | +5.45% | +10.41% | +40.45% | 125B | ||
| -3.23% | +3.51% | -13.00% | +15.96% | 190B | ||
| -2.75% | +11.65% | -8.47% | +18.50% | 124B | ||
| +0.96% | +5.15% | -37.16% | +12.09% | 99.31B | ||
| -1.80% | +0.82% | -7.52% | +70.12% | 63.65B | ||
| -0.78% | +7.07% | +19.14% | -17.27% | 57.71B | ||
| +0.79% | +22.65% | -4.57% | +60.02% | 53.26B | ||
| -6.98% | -14.56% | -11.97% | +46.23% | 47.03B | ||
| -2.36% | +3.72% | +3.86% | -7.99% | 36.15B | ||
| -0.30% | +23.41% | - | - | 34.83B | ||
| Average | -1.94% | +7.08% | -5.48% | +26.46% | 83.1B | |
| Weighted average by Cap. | -2.12% | +6.45% | -7.49% | +25.28% |
| 2027 * | 2028 * | |
|---|---|---|
| Net sales | 38.97B 34.95B 31.94B 29.16B 54.94B 3,663B 56.67B 385B 154B 1,955B 146B 143B 6,171B | 40.4B 36.23B 33.11B 30.23B 56.95B 3,798B 58.75B 399B 159B 2,026B 152B 148B 6,397B |
| Net income | 6.01B 5.39B 4.93B 4.5B 8.47B 565B 8.74B 59.37B 23.67B 301B 22.55B 22.07B 951B | 6.5B 5.83B 5.33B 4.86B 9.16B 611B 9.45B 64.23B 25.61B 326B 24.4B 23.88B 1,029B |
| Net Debt | 21.09B 18.92B 17.29B 15.78B 29.73B 1,983B 30.67B 208B 83.09B 1,058B 79.16B 77.46B 3,339B | 19.18B 17.21B 15.72B 14.35B 27.04B 1,803B 27.9B 190B 75.58B 962B 72.01B 70.46B 3,038B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-11-06 | US$101.80 | -2.90% | 7,451,289 |
| 26-11-05 | US$104.84 | -0.11% | 11,648,113 |
| 26-11-04 | US$104.96 | +6.15% | 11,572,398 |
| 26-11-03 | US$98.88 | -0.41% | 6,822,121 |
| 26-11-02 | US$99.29 | +2.85% | 8,771,563 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.

Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- MDT Stock
Select your edition
All financial news and data tailored to specific country editions

















